| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 9, 2022 | Feb 17, 2023 | Sonnet BioTherapeutics Holdings, Inc. | Director | Sell | 90.0 | +2,717 | 35.83% | ✗ | $518.4 |
| Dec 15, 2021 | Apr 8, 2022 | Sonnet BioTherapeutics Holdings, Inc. | Director | Sell | 90.0 | +10,493 | 10.97% | ✗ | $1.7K |
| May 25, 2021 | May 28, 2021 | Sonnet BioTherapeutics Holdings, Inc. | Director | Sell | 27.5 | -4,235 | -4.24% | ✗ | $6.4K |
| Nov 23, 2016 | Nov 28, 2016 | Outlook Therapeutics, Inc. | Director | Sell | 52.5 | -1 | 0.00% | ✗ | $3.8 |